A specific subset of low-grade NITAC has been designated as sinonasal seromucinous adenocarcinomas due to consistent expression of seromucinous differentiation markers, including DOG1, SOX10, and S-100 [9,11,12]. The gene discussed is ANO1; the disease is adenocarcinoma.